Drugs and the renin-angiotensin system in covid-19
- PMID: 32241880
- DOI: 10.1136/bmj.m1313
Drugs and the renin-angiotensin system in covid-19
Conflict of interest statement
Competing interests: JKA is a member of the Centre for Evidence-Based Medicine in Oxford, which jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with some international partners, which are based on a non-profit model. He is an associate editor of BMJ Evidence Based Medicine and was until recently vice-president publications for the British Pharmacological Society. REF was until recently a member of the Birmingham, Sandwell and Solihull Area prescribing committee, is a series editor of The BMJ’s Therapeutic Series, and has an honorary position in University College London. Provenance and peer review: Commissioned; not externally peer reviewed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous